EuGeni Rapid Antigen Test for the Qualitative Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Causing COVID19 Disease in Compliance With the World Health Organization (WHO)
Clinical trial NCT05618561 · TERMINATED
Trial details
- NCT number
- NCT05618561
- Sponsor
- AnteoTech Ltd
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-26
- Primary completion
- 2022-08-25
- Enrollment
- 599
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.